Literature DB >> 12069024

Sequelae after bacterial meningitis in childhood.

Rianne Oostenbrink1, Mariëlle Maas, Karel G M Moons, Henriëtte A Moll.   

Abstract

The neurological outcome of bacterial meningitis in children was evaluated retrospectively. Data were obtained from a large study on children aged between 1 month and 15 y who initially visited the emergency department of Sophia Children's Hospital, Rotterdam, The Netherlands with meningeal signs. This study presents data from 103 patients in whom bacterial meningitis was diagnosed. Neisseria meningitidis was the dominant pathogen of meningitis. We found a 2% case-fatality rate in children with bacterial meningitis and a 13% rate of sequelae among survivors: 7% hearing impairment and 7% neurological sequelae. Children with bacterial meningitis caused by Streptococcus pneumoniae and those with acute focal neurological symptoms tended to have the worst prognosis.

Entities:  

Mesh:

Year:  2002        PMID: 12069024     DOI: 10.1080/00365540110080179

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  14 in total

Review 1.  Bacterial meningitis: diagnosis and treatment.

Authors:  Russell D Snyder
Journal:  Curr Neurol Neurosci Rep       Date:  2003-11       Impact factor: 5.081

2.  Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis.

Authors:  Damian N Meli; Roney S Coimbra; Dominik G Erhart; Gerard Loquet; Caroline L Bellac; Martin G Täuber; Ulf Neumann; Stephen L Leib
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Factors influencing neurological outcome of children with bacterial meningitis at the emergency department.

Authors:  Fatiha Bargui; Irene D'Agostino; Patricia Mariani-Kurkdjian; Corinne Alberti; Catherine Doit; Nathalie Bellier; Laurence Morin; Giuliano Galli Gibertini; Assia Smail; Anna Zanin; Mathie Lorrot; Stéphane Dauger; Mathieu Neve; Albert Faye; Priscilla Armoogum; Antoine Bourrillon; Edouard Bingen; Jean-Christophe Mercier; Stéphane Bonacorsi; Lise E Nigrovic; Luigi Titomanlio
Journal:  Eur J Pediatr       Date:  2012-04-19       Impact factor: 3.183

Review 4.  Predicting sequelae and death after bacterial meningitis in childhood: a systematic review of prognostic studies.

Authors:  Rogier C J de Jonge; A Marceline van Furth; Merel Wassenaar; Reinoud J B J Gemke; Caroline B Terwee
Journal:  BMC Infect Dis       Date:  2010-08-05       Impact factor: 3.090

Review 5.  Early neurologic complications and long-term sequelae of childhood bacterial meningitis in a limited-resource country (Kosovo).

Authors:  Sadie A Namani; Bulëza M Koci; Zvonko Milenković; Remzie Koci; Emine Qehaja-Buçaj; Lindita Ajazaj; Murat Mehmeti; Vlora Ismaili-Jaha
Journal:  Childs Nerv Syst       Date:  2012-09-12       Impact factor: 1.475

Review 6.  Bacterial meningitis: the impact of vaccination.

Authors:  Nick Makwana; F Andrew I Riordan
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

7.  Meningococcal serogroup A, C, W₁₃₅ and Y conjugated vaccine: a cost-effectiveness analysis in the Netherlands.

Authors:  Hiltsje Hepkema; Koen B Pouwels; Arie van der Ende; Tjalke A Westra; Maarten J Postma
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  Significant sequelae after bacterial meningitis in Niger: a cohort study.

Authors:  Jean-François Jusot; Zilahatou Tohon; Abdoul Aziz Yazi; Jean-Marc Collard
Journal:  BMC Infect Dis       Date:  2013-05-21       Impact factor: 3.090

9.  Independent validation of an existing model enables prediction of hearing loss after childhood bacterial meningitis.

Authors:  Rogier C J de Jonge; Marieke S Sanders; Caroline B Terwee; Martijn W Heymans; Reinoud J B J Gemke; Irene Koomen; Lodewijk Spanjaard; A Marceline van Furth
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

10.  Predictors of long term neurological outcome in bacterial meningitis.

Authors:  Pratibha Singhi; Arun Bansal; P Geeta; Sunit Singhi
Journal:  Indian J Pediatr       Date:  2007-04       Impact factor: 5.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.